White CityOrganMini 3D volumetric bioprinter
Category:
White CityStar Products
Product Description

Anti-CT projection printing technology
This technology features non-contact and ultra-fast printing capabilities, overcoming the issues of slow printing speed and low cell survival rate associated with traditional contact bioprinters. Additionally, it is easy and quick to operate, with one-step molding, enabling the acquisition of centimeter-scale, highly viable three-dimensional tissues in just one minute.
High viability, High expression
The entire printing process takes place in a sealed printing bottle, utilizing visible light curing for integrated molding, rather than UV curing. It boasts fast printing speeds, no contact damage, no pollution, ensuring that the printed cell models maintain a cell survival rate of over 95% and a high expression levels*.
*Bernal et al. Advanced materials 2022


High-precision printing of structures
OrganMini employs a projection printing principle akin to "creating objects out of thin air", eliminating the need for supports or scaffolds to produce intricate three-dimensional models of complex structures such as microvessels, C60, skin, ears, and more. It also facilitates the simultaneous custom printing of multiple three-dimensional models.
*MB Xie, et al. Nature Communications, 2023
"One-click printing" software
We have specially designed the Haomiao printing software for OrganMini, which supports multi-user management. The software allows for fine adjustments of parameters such as position, rotation, size, light intensity, duration, and rotation speed. Additionally, the software comes pre-installed with a library of over 200 commonly used models to meet various needs.

Organoid construction leading solution
OrganMini boasts three core technological breakthroughs: 60-second ultra-fast integrated printing, which supports the simultaneous printing of multiple organoid microspheres, eliminating the significant batch-to-batch variability inherent in manual operations; Clinical validation has shown that this technology can shorten the organoid construction cycle to 7-14 days, with a drug screening accuracy rate of 83.3%.

Disruptive technology
Case1:The article exploring the mechanism by which ENO2 desensitizes colorectal cancer drugs has been published in Nature Metabolism。 Case2:Exploring the combination of pure silk fibroin ink and volumetric bioprinting, the article has been published in Nature Communication。 Case3:Exploring the relationship between decellularized extracellular matrix (dECM) and volumetric bioprinting, the article has been published in Advanced materials。

National Advisory Service Hotline
Sales consultation: +86 15322248165(Whatsapp/Wechat)
E-mail:global@newtonoptic.com
R & D Center: Room 301, Floor 1, Building 1, No.38 Gaopu Road, Tianhe District, Guangzhou City, Guangdong Province
Follow Wechat Official Account
©2024 Guangzhou Newtonoptic Research Institute Co., Ltd. All rights reserved